retatrutide regulatory approval FDA Status 2026: Everything We Know So Far This weight-loss drug hasn't been

Diabetes care 44 , 22162224 (2021)

The multidistrict litigation (MDL) against pharmaceutical giants Novo Nordisk and Eli Lilly, involving GLP-1 drugs such as Ozempic, Wegovy, Trulicity, and Mounjaro, continues to progress as plaintiffs claim these medications have caused serious gastrointestinal injuries

Additionally, it has been tested for other diseases, such as heart and renal diseases

Side Effects and Tolerability Tolerability determines real-world treatment success more than raw efficacy numbers

Learn more about Weight Loss by Hers Hers subscription benefits: Hers can connect users to medical providers who specialize in a range of prescription treatment options depending on your needs